• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2009

View Archived Issues

Naltrexone implant shown to be safe and effective in heroin dependence

Read More

Novel bacterial signal transduction inhibitors in development at Kinki University

Read More

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Read More

Exclusive licensing agreement signed to market Zolpimist in U.S. and Canada

Read More

FDA approves NeurogesX's Qutenza for neuropathic pain due to postherpetic neuralgia

Read More

ARCA biopharma to submit study protocol for Gencaro trial under the FDA's SPA

Read More

PPD and Janssen to develop two phase II drugs for IBS-D and bacterial infections

Read More

Novartis reports interim data from ongoing clinical trials of influenza A vaccine

Read More

GP Pharm files NDA for Lutrate in five European countries

Read More

Data from phase III trials support safety and efficacy of tenofovir DF in CHB patients

Read More

Clinical data reported for boceprevir plus PegIntron/ribavirin in HCV

Read More

Rifaximin exhibits durable long-term protection in hepatic encephalopathy trial

Read More

Clinical data presented from 3 trials on sorafenib for HCC therapy

Read More

Cosmo Pharmaceuticals offers to acquire BioXell

Read More

Phase I data on JNJ-26483327 in solid tumors reported at 2009 AACR-NCI-EORTC meeting

Read More

Gruenenthal presents a new series of ORL1 and mu-opioid receptor ligands

Read More

Glucokinase activators for the treatment of diabetes described by Merck KGaA

Read More

FDA approves GlaxoSmithKline's pandemic H1N1 vaccine

Read More

New mGluR2 receptor ligands for the treatment of epilepsy disclosed by sanofi-aventis

Read More

Genentech submits sBLAs to FDA for first-line Avastin treatment of breast cancer

Read More

NeuroSearch claims novel dopamine and serotonin receptor modulators

Read More

Medical Therapies becomes Cellmid

Read More

Sequella and NIH sign new exclusive worldwide licensing agreement for SQ-109

Read More

FDA committee to review OSI's Tarceva as first-line maintenance therapy for NSCLC

Read More

FDA grants EUA to Roche's RealTime Ready Influenza A/H1N1 Detection Set

Read More

FDA accepts for filing NicOx's NDA for naproxcinod in osteoarthritis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 4, 2025.
  • Pill with British pound sign

    Pharma execs speak out: UK pricing rebates scare investors

    BioWorld
    The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 3, 2025
  • Kymera’s phase I data lead big week for STAT6 space

    BioWorld
    It’s a good week to be working on drugs targeting STAT6. Kymera Therapeutics Inc.’s, KT-621, the first oral STAT6 degrader candidate to enter the clinic,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe